A handful of extreme moves set the tone, from DXN’s explosive AI data centre rerating to steep sell-offs in small-cap explorers. Deals, funding and fresh drilling results drove the week, but several gap-ups lost steam as traders banked profits.
- DXN surged 775% after landing an AI high-performance computing contract with a large follow-on revenue target.
- Resources names stayed busy as rare earths, gold, silver and copper stories kept feeding the tape.
- M&A and capital management lifted sentiment in Heartland, Tasmea, Matrix, Magnetic and Nova Minerals.
- Several stocks opened strongly on news, then gave back ground as early buying faded.
DXN Limited (ASX:DXN) dominated the week with a gain of 775.00% after it announced an A$8.8 million AI high-performance computing modular data centre contract with a US neo-cloud operator. Investors cared because the deal was not just a one-off build. The company also pointed to possible follow-on revenue of more than US$200 million over 12 years. At the other end, Litchfield Minerals (ASX:LMS) plunged 47.92%, even as it reported broad copper-zinc intersections and a new nickel-molybdenum vein. That kind of disconnect often means investors wanted faster proof that drilling can turn into a resource. Control Bionics (ASX:CBL) rallied 41.07% on new distribution deals, insurance reimbursement wins and wider market access in the US and Europe, which matters because reimbursement is simply the step where health insurers agree to pay.
AI and health names drew the strongest buying
Megaport (ASX:MP1) climbed 23.27% after securing four AI infrastructure contracts worth A$459 million and launching an A$827 million raising to fund a global GPU pool. In plain English, investors liked the revenue jump, but they also had to weigh the cost of issuing a lot of new shares. Biome Australia (ASX:BIO) added 26.88% as it moved probiotic production onshore without upfront capital spending. That mattered because higher margins mean the company keeps more from each sale. Vitrafy Life Sciences (ASX:VFY) rose 25.48% after signing with Vitalant to work on blood preservation in the US. The story was simple: a legacy freezing method is being phased out, and Vitrafy is trying to fill that gap. Pacific Edge (ASX:PEB) also gained 11.11% after an oversubscribed NZ$36.1 million raising, suggesting existing investors were willing to keep backing the bladder cancer test rollout.Resources stayed busy, but not every good drill hole lifted the share price
IperionX (ASX:IPX) fell 6.86% despite a definitive feasibility study for Titan showing an after-tax net present value of US$813 million and a 39.4% internal rate of return. Those are finance terms for expected project value and estimated return, and they were strong. The drop suggests some investors had already priced in good news. DPM Metals (ASX:DPM) rose 10.07% after reporting 713 metres at 2.52 grams per tonne gold equivalent near Chelopech. That caught attention because long mineralised intervals can support a bigger mine. Helix Resources (ASX:HLX) jumped 37.15% after lifting the Gold Basin resource in Arizona to 280,000 ounces, while Magnum Mining (ASX:MGU) gained 27.27% as its rare earth drilling campaign pushed towards a resource milestone later this year. Even so, this part of the market was patchy. Dart Mining (ASX:DTM) dropped 21.74% although it posted strong antimony-gold assays. The stock reopened and then sank further, which suggests holders used the announcement to sell. Somerset Minerals (ASX:SMM) lost 38.46% despite high-grade copper at Jura, and Middle Island Resources (ASX:MDI) slid 19.05% after broad polymetallic hits in Serbia. In small explorers, a good assay is not always enough. Investors still want to know how big the deposit might become, how much drilling will cost, and how long it could take to move forward.Deals and balance sheet moves helped financials and industrials
Heartland Group Holdings (ASX:HGH) rose 9.84% after agreeing to buy TSB Bank for NZ$620 million. Investors liked the promised cost savings and forecast earnings lift, because those are direct reasons a bank merger can add value. Tasmea (ASX:TEA) advanced 16.74% as the market absorbed both its A$254 million Maxim acquisition and a fully franked 10 cent special dividend. That combination matters: one item points to growth, the other puts cash straight back into shareholders’ hands. SRG Global (ASX:SRG) rallied 21.66% after locking in A$1.85 billion in contracts and lifting earnings guidance. Monadelphous (ASX:MND), by contrast, slipped 1.74% despite landing a A$380 million power plant contract, a sign that investors may have seen the news as solid but not surprising. Corporate activity stayed heavy elsewhere. Magnetic Resources (ASX:MAU) edged down 0.26% after shareholders backed the Genesis takeover, which is common once a bid price becomes the main anchor for trading. Matrix Composites & Engineering (ASX:MCE) was flat after lodging its scheme booklet, while Nova Minerals (ASX:NVA) added 1.32% across its US holding company restructure and court approval. Those moves were modest because the key terms were already known.Some early jumps held, while others faded quickly
Several stocks showed a clear split between the first reaction and where they finished. Templeton Emerging Markets Investment Trust (ASX:TEM) ended the week up 9.09% after a strong annual result, and the stock kept running after reopening. That points to sustained buying rather than a brief spike. DPM Metals (ASX:DPM) and Helix (ASX:HLX) showed the same pattern. In plain English, buyers stayed interested after the first wave. Other names lost energy after the open. Heartland still finished higher, but the move after reopening was much smaller than the weekly gain. PhosCo (ASX:PHO), Jade Gas (ASX:JGH) and Theta Gold Mines (ASX:TGM) also rose for the week while trading softened after the initial burst. That usually means traders liked the news but took quick profits. Then there were sharper air pockets, where selling deepened after trading resumed. Litchfield, Dart, Sky Metals (ASX:SKY), Barton Gold (ASX:BGD), Frontier Energy (ASX:FHE) and DroneShield (ASX:DRO) all fit that shape. In each case, investors either worried about dilution, timing, or whether the announcement changed earnings soon enough.What the week said about risk appetite
The clearest winners were companies that delivered a near-term commercial reason to believe revenue could rise fast, or costs could fall in a measurable way. That explains the strength in DXN, Megaport, Biome, SRG Global and Control Bionics. Resource stocks still attracted heavy trading, but buyers were more selective. A new resource, a feasibility study or funding line helped. Raw exploration news on its own often was not enough. For beginners, the lesson is simple: the market paid more for news that changed expected cash coming in or cash going out, and it punished stories that still need several more steps before money can be made.Bottom Line?
The next stretch will turn on dated milestones already on the calendar, including Nova Minerals’ mid-June implementation, Dreadnought’s July resource update, BCM’s June bankable feasibility study target, and Heartland’s much longer approval track towards December 2026. Investors will also be watching whether AI contracts, project finance and takeover steps keep converting into firmer earnings and development progress.
Questions in the middle?
- Can DXN turn its pilot AI data centre contract into the much larger follow-on revenue it flagged?
- Will recent funding rounds at companies like Megaport, Frontier Energy and Barton Gold produce visible progress fast enough to justify dilution?
- Which exploration names can convert strong drilling news into a larger resource estimate, rather than just a short-lived trading spike?